换一批Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay.
第一作者：
Sarah,Schott
第一单位：
Department of Gynaecology and Obstetrics, National Center for Tumour Diseases, University of Heidelberg, 69115 Heidelberg, Germany.
作者：
医学主题词
腺苷三磷酸(Adenosine Triphosphate);阿屈膦酸盐(Alendronate);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);乳腺肿瘤(Breast Neoplasms);细胞死亡(Cell Death);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);二膦酸盐类(Diphosphonates);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);女(雌)性(Female);氟尿嘧啶(Fluorouracil);人类(Humans);咪唑类(Imidazoles);半数抑制浓度(Inhibitory Concentration 50);卵巢肿瘤(Ovarian Neoplasms);参考标准(Reference Standards)
DOI
10.1007/s10637-011-9688-3
PMID
21604021
发布时间
2021-10-20
- 浏览14
Investigational new drugs
1750-5页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
